(Glu1)-Fibrinopeptide B (human) is a peptide derived from the N-terminal region of fibrinogen, playing a key role in blood clotting processes. The glutamic acid at position 1 enhances its solubility in aqueous systems, supporting its application in coagulation and fibrinolysis studies. This compound serves as a valuable reagent in assays investigating thrombin-mediated fibrin formation and platelet aggregation.
CAT No: F03003
CAS No:103213-49-6
Synonyms/Alias:103213-49-6;(Glu1)-Fibrinopeptide B (human);DTXSID80583245;GLU-GLY-VAL-ASN-ASP-ASN-GLU-GLU-GLY-PHE-PHE-SER-ALA-ARG;L-alpha-Glutamylglycyl-L-valyl-L-asparaginyl-L-alpha-aspartyl-L-asparaginyl-L-alpha-glutamyl-L-alpha-glutamylglycyl-L-phenylalanyl-L-phenylalanyl-L-seryl-L-alanyl-L-arginine;DTXCID80534010;MFCD00076440;FG108819;[Glu1]-Fibrinopeptide B human, >=90% (HPLC);Fibrinopeptide b(human),1-L-glutamic acid-(9ci);H-Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH; H-EGVNDNEEGFFSAR-OH;
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.